Virus-induced neurobehavioral disorders: Mechanisms and implications

Trends in Molecular Medicine

Volumn 10, Issue 2, 2004, Pages 71-77

  Tomonaga, Keizo ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; SEROTONIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL BEHAVIOR; BEHAVIOR DISORDER; BRAIN INFECTION; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; GLIA CELL; HUMAN; ILLNESS BEHAVIOR; LEARNING DISORDER; LOCOMOTION; MEMORY DISORDER; MENTAL DISEASE; MOLECULAR BIOLOGY; MOTOR DYSFUNCTION; NEUROPSYCHIATRY; NONHUMAN; PATHOGENESIS; REVIEW; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; SOCIAL BEHAVIOR; VIRUS INFECTION;

ANIMALIA;

EID: 1142309838     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2003.12.001     Document Type: Review

References (68)

1. Cowan W.M., et al. The human genome project and its impact on psychiatry. Annu. Rev. Neurosci. 25:2002;1-50.
2. Brown A.S., Susser E.S. In utero infection and adult schizophrenia. Ment. Retard. Dev. Disabil. Res. Rev. 8:2002;51-57.
3. Kamitani W., et al. Glial expression of borna disease virus phosphoprotein induces behavioral and neurological abnormalities in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 100:2003;8969-8974.
4. Tyler K.L., Nathanson N. Pathogenesis of viral infections. Knipe D.M., Howley P.M. Fields Virology. 2001;199-243 Lippincott Williams and Wilkins.
5. Konsman J.P., et al. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci. 25:2002;154-159.
6. Kelley K.W., et al. Cytokine-induced sickness behavior. Brain Behav. Immun. 17:(Suppl 1):2003;S112-S118.
7. Hornig M., et al. Borna disease viral infection of adult and neonatal rats: models for neuropsychiatric disease. Curr. Top. Microbiol. Immunol. 253:2001;157-177.
8. Conn C.A., et al. Cytokines and the acute phase response to influenza virus in mice. Am. J. Physiol. 268:1995;R78-R84.
9. Herden C., et al. Distribution of Borna disease virus in the brain of rats infected with an obesity-inducing virus strain. Brain Pathol. 10:2000;39-48.
10. Toth L.A., et al. Strain differences in sleep and other pathophysiological sequelae of influenze virus infection in naïve and immunized, ice. J. Immunol. 58:1995;89-99.
11. Prospero-Garcia O. Sleep patterns are disturbed in cats infected with feline immunodeficiency virus. Proc. Natl. Acad. Sci. U. S. A. 91:1994;12947-12951.
12. Weed M.R., Gold L.H. Paradigms for behavioral assessment of viral pathogenesis. Adv. Virus Res. 56:2001;583-626.
13. Mohammed A.H., et al. Viruses and behavioural changes: a review of clinical and experimental findings. Rev. Neurosci. 4:1993;267-286.
14. Pletnikov M.V., et al. Persistent neonatal Borna disease virus (BDV) infection of the brain causes chronic emotional abnormalities in adult rats. Physiol. Behav. 66:1999;823-831.
15. Pletnikov M.V., et al. Developmental brain injury associated with abnormal play behavior in neonatally Borna disease virus-infected Lewis rats: a model of autism. Behav. Brain Res. 100:1999;43-50.
16. Nelson R.J., Chiavegatto S. Molecular basis of aggression. Trends Neurosci. 24:2001;713-719.
17. Miczek K.A., et al. Aggressive behavioral phenotypes in mice. Behav. Brain Res. 125:2001;167-181.
18. Charlton K.M., et al. Experimental rabies in skunks: effects of immunosuppression induced by cyclophosphamide. Can. J. Comp. Med. 48:1984;72-77.
19. Narayan O., et al. Pathogenesis of Borna disease in rats: immune-mediated viral ophthalmoencephalopathy causing blindness and behavioral abnormalities. J. Infect. Dis. 148:1983;305-315.
20. Ben-Hur T., et al. A novel permissive role for glucocorticoids in induction of febrile and behavioral signs of experimental herpes simplex virus encephalitis. Neuroscience. 108:2001;119-127.
21. Moshkin M., et al. Behavior, chemosignals and endocrine functions in male mice infected with tick-borne encephalitis virus. Psychoneuroendocinology. 27:2002;603-608.
22. Griffin D.E., Hardwick J.M. Perspective: viral infections and the death of neurons. Trends Microbiol. 7:1999;155-160.
23. Tomonaga K., et al. Molecular and cellular biology of Borna disease viral infection. Microbes Infect. 4:2002;491-500.
24. Benedict C.A., et al. To kill or be killed: viral evasion of apoptosis. Nat. Immunol. 3:2002;1013-1018.
25. Gale M. Jr, Katze M.G. Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol. Ther. 78:1998;29-46.
26. Irani D.N., Griffin D.E. Regulation of T cell responses during central nervous system viral infection. Adv. Virus Res. 56:2001;175-197.
27. Bilzer T., Stitz L. Immune-mediated brain atrophy. CD8+T cells contribute to tissue destruction during Borna disease. J. Immunol. 153:1994;818-823.
28. Fazakerley J.K., Walker R. Virus demyelination. J. Neurovirol. 9:2003;148-164.
29. Kaul M., et al. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature. 410:2001;988-994.
30. Ankarcrona M., et al. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron. 15:1995;961-973.
31. Licinio J., Wong M.L. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol. Psychiatry. 4:1999;317-327.
32. Patarca R. Cytokines and chronic fatigue syndrome. Ann. N. Y. Acad. Sci. 933:2001;185-200.
33. Montkowski A., et al. Central administration of IL-1 reduces anxiety and induces sickness behaviour in rats. Pharmacol. Biochem. Behav. 58:1997;329-336.
34. Kent S., et al. Mechanisms of sickness-induced decreases in food-motivated behavior. Neurosci. Biobehav. Rev. 20:1996;171-175.
35. Bluthe R.M., et al. Mechanisms of the behavioral effects of interleukin 1. Role of prostaglandins and CRF. Ann. N. Y. Acad. Sci. 650:1992;268-275.
36. Burgess W., et al. Interleukin-1β-converting enzyme-deficient mice resist central but not systemic endotoxin-induced anorexia. Am. J. Physiol. 274:1998;R1829-R1833.
37. Dantzer R. Cytokine-induced sickness behavior: where do we stand? Brain Behav. Immun. 15:2001;7-24.
38. Dunn A.J. Cytokine activation of the HPA axis. Ann. N. Y. Acad. Sci. 917:2000;608-617.
39. Nestler E.J., et al. Neurobiology of depression. Neuron. 34:2002;13-25.
40. Manji H.K., et al. The cellular neurobiology of depression. Nat. Med. 7:2001;541-547.
41. Allan S.M., Rothwell N.J. Cytokines and acute neurodegeneration. Nat. Rev. Neurosci. 2:2001;724-744.
42. Giulian D., et al. Brain glia release factors with opposing actions upon neuronal survival. J. Neurosci. 13:1993;29-37.
43. Nguyen M.D., et al. Innate immunity: the missing link in neuroprotection and neurodegeneration. Nat. Rev. Neurosci. 3:2002;216-227.
44. Park C., et al. Expression of fas antigen in the normal mouse brain. Biochem. Biophys. Res. Commun. 252:1998;623-628.
45. Sekine, Y. et al. Correlations between in vitro affinity of antipsychotics to various central neurotransmitter receptors and clinical incidence of their adverse drug reactions. Eur. J. Clin. Pharmacol. 55, 583-587.
46. Azmitia E.C. Serotonin neurons, neuroplasticity, and homeostasis of neural tissue. Neuropsychopharmacology. 21:1999;33s-45s.
47. Kumar A.M., et al. Cerebrospinal fluid 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in HIV-1 infection. Neuropsychobiology. 44:2001;13-18.
48. Altar C.A. Neurotrophins and depression. Trends Pharmacol. Sci. 20:1999;59-61.
49. Overstreet D.H., et al. Involvement of 5-HT1A receptors in animal tests of anxiety and depression: evidence from genetic models. Stress. 6:2003;101-110.
50. Mehta S., Kitchen I. Regional changes in 5-HT1A but not in 5-HT2A receptors in mouse brain after Semliki Forest viral infection: radioligand binding and autoradiographic studies. J. Neurovirol. 4:1998;606-618.
51. Ceccaldi P.E., et al. Rabies virus selectively alters 5-HT1 receptor subtypes in rat brain. Eur. J. Pharmacol. 245:1993;129-138.
52. Pletnikov M.V., et al. Effects of genetic background on neonatal Borna disease viral infection-induced neurodevelopmental damage. II. Neurochemical alterations and responses to pharmacological treatments. Brain Res. 944:2002;108-123.
53. Sawa A., Snyder S.H. Schizophrenia: diverse approaches to a complex disease. Science. 296:2002;692-695.
54. Cotter D.R., et al. Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res. Bull. 55:2001;585-595.
55. Moises H.W., et al. The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia. BMC Psychiatry. 2:2002;8.
56. Tkachev D., et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet. 362:2003;798-805.
57. Hakak Y., et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 98:2001;4746-4751.
58. Pfrieger F.W., Barres B.A. Synaptic efficacy enhanced by glial cells in vitro. Science. 277:1997;1684-1687.
59. Fields R.D., Stevens-Graham B. New insights into neuron-glia communication. Science. 298:2002;556-562.
60. Ullian E.M., et al. Control of synapse number by glia. Science. 291:2001;657-661.
61. Wyss-Coray T., Mucke L. Inflammation in neurodegenerative disease - a double-edged sword. Neuron. 35:2002;419-432.
62. Kamitani W., et al. Borna disease virus phosphoprotein binds a neurite outgrowth factor, amphoterin/HMG-1. J. Virol. 75:2001;8742-8751.
63. Rauvala H., et al. Heparin-binding proteins HB-GAM (pleiotrophin) and amphoterin in the regulation of cell motility. Matrix Biol. 19:2000;377-387.
64. Daston M.M., Ratner N. Amphoterin (P30, HMG-1) and RIP are early markers of oligodendrocytes in the developing rat spinal cord. J. Neurocytol. 23:1994;323-332.
65. Carbone K.M. Borna disease virus and human disease. Clin. Microbiol. Rev. 14:2001;513-527.
66. Karlsson H., et al. Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 98:2001;4634-4639.
67. Ikuta K., et al. Borna disease virus and infection in humans. Front. Biosci. 7:2002;D470-D495.
68. Dickerson F.B., et al. Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia. Arch. Gen. Psychiatry. 60:2003;466-472.